Table 5.
Subgroup Analyses
| Subgroup | Diabetic status | Calcification | Gender | Smoking status | ||||
|---|---|---|---|---|---|---|---|---|
| Diabetic | Not diabetic | Calcification | No Calcification | Female | Male | Current smoker | Not a current smoker | |
| Sample Size (subjects/lesions) | 17/21 | 33/37 | 31/36 | 20/22 | 19/20 | 31/38 | 26/28 | 24/30 |
| Mean Lesion Length | 7.0 ± 4.8 | 7.3 ± 4.7 | 8.0 ± 4.7 | 6.0 ± 4.4 | 7.8 ± 5.1 | 6.9 ± 4.5 | 7.0 ± 4.7 | 7.4 ± 4.7 |
| Calcification | 61.9% (13/21) | 62.2% (23/37) | 100% (36/36) | 0% | 50% (10/20) | 68.4% (26/38) | 64.3% (18/28) | 60.0% (18/30) |
| Severe Calcification | 9.5% (2/21) | 16.2% (6/37) | 22.2% (8/36) | 0% | 15% (3/20) | 13.2% (5/38) | 7.1% (2/28) | 20% (6/30) |
| Total occlusions | 4.8% (1/21) | 16.2% (6/37) | 16.7% (6/36) | 4.5% (1/22) | 10% (2/20) | 13.2% (5/38) | 17.9% (5/28) | 6.7% (2/30) |
| 12‐Month patencya | 80.4% | 94.6% | 86.4% | 91.4% | 90% | 89.3% | 92.9% | 86.4% |
| 24‐Month patencya | 63.3% | 88.9% | 74.5% | 83.6% | 90% | 74.5% | 84.8% | 76.5% |
| P‐valueb | 0.056 | 0.393 | 0.273 | 0.588 | ||||
a
Per Kaplan‐Meier Estimate.
b
Log‐Rank Test.